A lawyer who has proved her business mettle, Schulman is both general counsel and head of Pfizer’s $3.2 billion consumer health care division. Come January, she’ll leave the legal department entirely to oversee vaccines, oncology, and consumer health care, a newly created $8.6 billion group.